Skip to search formSkip to main contentSkip to account menu

Binocrit

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Background: OncoBOS is a national, prospective, non-interventional, longitudinal, observational study describing biosimilar… 
2013
2013
All prescribers will be familiar with the issues associated with the use of branded and generic ‘chemical’ medicines.1 For… 
2013
2013
Background The patent expiries of leading biological products and the development of biosimilars create opportunities for cost… 
2012
2012
There are concerns that biosimilar erythropoiesis-stimulating agents (ESAs) are less effective than the originator ESAs. The… 
Review
2011
Review
2011
Along with expired patent protection for several drugs obtained using biotechnology several new preparations emerged called… 
2009
2009
  • 2009
  • Corpus ID: 39950183
The first copy of Eprex, a product containing epoetin alfa, has been marketed in France, under the name Binocrit.